GelStat Stock Price (OTCBB:GSAC)

Add to My Stocks
$0 $0 (0%) GSAC stock closing price Sep 18, 2018 (Closing)
Prev Close* : $0
Market Cap:
$0.6M
Day Low: $0
52 Week Low: $0.00
Open: $0
Volume: $0
Day High: $0
52 Week High: $0.01
Dividend:
0.00

Latest Stock Market News

Latest Articles

GSAC Stockcharts

View GSAC PE ratio, PS ratio stocks charts and compare with peers.
GSAC Chart
Note: Compare GelStat stock price history with the index and industry peers.

GelStat Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
-999.0000
PB ratio (
price to book ratio
)
-999.0000

GelStat Returns

ROE
(return on equity)

GelStat Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity
Dividend Yield
-999.0000

GSAC Industry Peers

Top Stock Gainers

show top losers
CompanyPriceChange (%)
ChemoCentryx (CCXI)11.521.03 (9.82%)
AcelRx Pharma (ACRX)3.750.3 (8.7%)
MELINTA THERAPT (MLNT)4.450.35 (8.54%)
Galectin Therapeutics (GALT)6.020.28 (4.88%)
GlycoMimetics (GLYC)14.580.67 (4.82%)
Achaogen (AKAO)4.280.17 (4.14%)
Concert Pharma (CNCE)13.420.51 (3.95%)
Top gainers from Medical-Drugs industry
* As of Sep 19, 2018
CompanyPriceChange (%)
MADRIGAL PHARMA (MDGL)207.321.13 (9.25%)
Tetraphase Pharmaceuticals (TTPH)2.90.16 (5.23%)
Recro Pharma (REPH)7.410.29 (3.77%)
Corcept Therapeutics (CORT)14.260.48 (3.26%)
Lannett Co (LCI)4.750.15 (3.06%)
Catalyst Pharma (CPRX)3.10.09 (2.82%)
Galmed Pharma (GLMD)12.610.24 (1.87%)
Top losers from Medical-Drugs industry
* As of Sep 19, 2018

GelStat Financial Statements

income statement20142008
Net Sales or Revenues1.31M-
Net Income-1.3M-0.46M
Total Operating Expense00
View GelStat income statement
balance sheet2008
Total Assets-
Total Liabilities2.23M
Shareholders Equity-2.18M
View GelStat balance sheet
cash flow statement2008
Net Increase (Decrease) in Assets Liabilities-
Net Cash from (used by) Operating Activities-0.08M
Increase (Decrease) in Prop Plant And Equipment-
View GelStat cash flow statement

GelStat Stock Message Board

GelStat stock lost 0%, and the last close price as of Sep 18, 2018 is $0 for GSAC stock. The total market value as denoted by $0.6M for GelStat, is the market value of the company's outstanding shares. Investors can use valuation multiples like the P/E ratio, price to sales ratio etc. for performing GelStat stock analysis.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that GelStat is worth a lot, it will most likely be reflected in an inflated GelStat stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. 0 GSAC shares were traded yesterday, and GelStat stock chart shows that the GSAC stock quote hit a day high of $0 and day low of $0. A dividend is a cash payment made from a company's earnings and is distributed among shareholders. GelStat does not pay dividends. One can observe stock price trends and check for volatility by checking GelStat stock price history.

Related to GelStat Stock Quotes

Stocks from Medical-Drugs, GelStat stock price history,